elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35188148-0CD0A6AA-CFA8-4300-AECF-F108F98E3918
Q35188148-0CD0A6AA-CFA8-4300-AECF-F108F98E3918
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35188148-0CD0A6AA-CFA8-4300-AECF-F108F98E3918
Subchronic administration and combination metabotropic glutamate and GABAB receptor drug therapy in fragile X syndrome.
P2860
Q35188148-0CD0A6AA-CFA8-4300-AECF-F108F98E3918
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35188148-0CD0A6AA-CFA8-4300-AECF-F108F98E3918
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0c89a95abe470c4a4a2a44f47cc32f335a230055
P2860
Suppression of two major Fragile X Syndrome mouse model phenotypes by the mGluR5 antagonist MPEP.